<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04890275</url>
  </required_header>
  <id_info>
    <org_study_id>ER15905458</org_study_id>
    <nct_id>NCT04890275</nct_id>
  </id_info>
  <brief_title>Blood Flow Restricted Resistance Training in Peripheral Arterial Disease</brief_title>
  <official_title>Blood Flow Restricted Resistance Training in Peripheral Arterial Disease: a Randomised Controlled Trial Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheffield Hallam University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sheffield Teaching Hospitals NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sheffield Hallam University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomised controlled trial evaluating the feasibility and acceptability of a 12 week lower&#xD;
      body blood flow restricted resistance exercise programme for people with peripheral arterial&#xD;
      disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary aim of this study is to determine the feasibility of 12 weeks of lower body&#xD;
      resistance exercise performed with blood flow restriction (BFR) in people with peripheral&#xD;
      arterial disease.&#xD;
&#xD;
      Resistance exercise with BFR involves placing inflatable cuffs proximal to the exercise limbs&#xD;
      in order to manipulate blood flow and enhance the training response.&#xD;
&#xD;
      Secondary aim of this study is to evaluate changes in ABPI, muscle size, strength and&#xD;
      physical function at mid-and post- intervention.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 21, 2021</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recruitment Rates</measure>
    <time_frame>3 months</time_frame>
    <description>Defined as rate of invited participants who are eligible and consenting.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Retention Rates</measure>
    <time_frame>3 months</time_frame>
    <description>Retention rates will be established as discontinuation with the exercise intervention and absence from the assessment sessions.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acceptability of allocation</measure>
    <time_frame>3 months</time_frame>
    <description>will be assessed by attrition rates, comparing participant withdrawal between experimental and control groups and reasons for dropout where appropriate.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acceptability of the exercise study</measure>
    <time_frame>3 months</time_frame>
    <description>Will be evaluated by participants feedback via one-to-one semi-structured interviews.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Completion Rates</measure>
    <time_frame>3 months</time_frame>
    <description>Completion is determined by participants that attend baseline testing and post exercise intervention testing.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in PAD severity</measure>
    <time_frame>3 months</time_frame>
    <description>ankle-brachial pressure index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in muscle size</measure>
    <time_frame>3 months</time_frame>
    <description>Size of vastus lateralis measured via ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in strength</measure>
    <time_frame>3 months</time_frame>
    <description>Unilateral isometric maximal voluntary contraction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in walk ability</measure>
    <time_frame>3 months</time_frame>
    <description>Measured via the 6-minute walk test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in physical function</measure>
    <time_frame>3 months</time_frame>
    <description>Measured via timed up-and-go test</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <arm_group>
    <arm_group_label>BFR</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will participate in a supervised low load lower body blood flow restriction resistance exercise program twice a week for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NON-BFR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will participate in a supervised low load lower resistance exercise program twice a week for 12 weeks (matched training volume as experimental arm but without BFR)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood flow restricted resistance exercise (BFR)</intervention_name>
    <description>Following a 5-minute low intensity warm-up, the BFR cuff will be placed at the most proximal portion of the leg inflated to 50% limb occlusion following standard BFR guidelines. Participants will then perform leg press including 1 set of 30 reps, then 3 sets of 15 reps at 20% 1RM. Rest for 5 minutes without cuff inflation. Cuffs will be re inflated and participants will perform knee extension including 3 x 15 repetitions at 20% 1RM.</description>
    <arm_group_label>BFR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Resistance exercise without blood flow restricted (NON-BFR)</intervention_name>
    <description>Participants will follow the same exercise protocol as the blood flow restriction group but with out BFR.</description>
    <arm_group_label>NON-BFR</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Men and women with PAD 6 months post diagnosis.&#xD;
&#xD;
          -  Ankle-brachial pressure index &lt;0.9.&#xD;
&#xD;
          -  People physically able to perform leg press and leg extension resistance exercise.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Ankle-brachial pressure index &gt;0.89.&#xD;
&#xD;
          -  People unable to visit the laboratory twice weekly for exercise sessions.&#xD;
&#xD;
          -  People unable to do leg press and leg extension exercise.&#xD;
&#xD;
          -  People whose walking is limited by a non-PAD condition.&#xD;
&#xD;
          -  People with PAD with critical limb ischemia (including symptoms of pain at rest and&#xD;
             skin ulcers).&#xD;
&#xD;
          -  People with Dementia.&#xD;
&#xD;
          -  People who have had major surgery or myocardial infarction within the past 6 months.&#xD;
&#xD;
          -  Previous stroke.&#xD;
&#xD;
          -  Previous thrombosis.&#xD;
&#xD;
          -  People who have major surgery scheduled during the intervention period.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Thomas Parkington</last_name>
    <phone>07881298622</phone>
    <email>t.parkington@shu.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Markos Klonizakis</last_name>
    <email>m.klonizakis@shu.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sheffield Hallam University</name>
      <address>
        <city>Sheffield</city>
        <state>South Yorkshire</state>
        <zip>s10 2BP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Thomas Parkington</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 4, 2021</study_first_submitted>
  <study_first_submitted_qc>May 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2021</study_first_posted>
  <last_update_submitted>September 24, 2021</last_update_submitted>
  <last_update_submitted_qc>September 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Blood flow restricted resistance exercise</keyword>
  <keyword>Feasability</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

